The complement system, toll-like receptors and inflammasomes in host defense: three musketeers’ one target

References

• Buchmann K. Evolution of innate immunity: clues from invertebrates via fish to mammals. Front Immunol 2014;5:459. doi:10.3389/fimmu.2014.00459.
   PubMed Web of Science ®Google Scholar
• Lamkanfi M, Dixit VM. Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol 2012;28:137–161. doi:10.1146/annurev-cellbio-101011-155745.
   PubMed Web of Science ®Google Scholar
• Place DE, Kanneganti TD. Recent advances in inflammasome biology. Curr Opin Immunol 2018;50:32–38. doi:10.1016/j.coi.2017.10.011.
   PubMed Web of Science ®Google Scholar
• Dolasia K, Bisht MK, Pradhan G, et al. TLRs/NLRs: shaping the landscape of host immunity. Int Rev Immunol 2018;37(1):3–19. doi:10.1080/08830185.2017.1397656.
   PubMed Web of Science ®Google Scholar
• Roozendaal R, Carroll MC. Emerging patterns in complement-mediated pathogen recognition. Cell 2006;125(1):29–32. doi:10.1016/j.cell.2006.03.018.
   PubMed Web of Science ®Google Scholar
• Kemper C, Atkinson JP, Hourcade DE. Properdin: emerging roles of a pattern-recognition molecule. Annu Rev Immunol 2010;28(1):131–155. doi:10.1146/annurev-immunol-030409-101250.
   PubMedGoogle Scholar
• Lee MS, Kim YJ. Pattern-recognition receptor signaling initiated from extracellular, membrane, and cytoplasmic space. Mol Cells 2007;23:1–10.
   PubMed Web of Science ®Google Scholar
• Kolev M, Le Friec G, Kemper C. Complement–tapping into new sites and effector systems. Nat Rev Immunol 2014;14(12):811–820. doi:10.1038/nri3761.
   PubMed Web of Science ®Google Scholar
• Ricklin D, Lambris JD. Complement therapeutics. Semin Immunol. 2016;28(3):205–207. doi:10.1016/j.smim.2016.07.001.
   PubMed Web of Science ®Google Scholar
• Ricklin D, Reis ES, Mastellos DC, et al. Complement component C3 – the “Swiss Army Knife” of innate immunity and host defense. Immunol Rev 2016;274(1):33–58. doi:10.1111/imr.12500.
   PubMed Web of Science ®Google Scholar
• Ricklin D, Reis ES, Lambris JD. Complement in disease: a defence system turning offensive. Nat Rev Nephrol 2016;12(7):383–401. doi:10.1038/nrneph.2016.70.
   PubMed Web of Science ®Google Scholar
• West EE, Kolev M, Kemper C. Complement and the regulation of T cell responses. Annu Rev Immunol 2018;36:309–338. doi:10.1146/annurev-immunol-042617-053245.
   PubMed Web of Science ®Google Scholar
• Kumar V. Toll-like receptors in immunity and inflammatory diseases: past, present, and future. Int Immunopharmacol 2018;59:391–412. doi:10.1016/j.intimp.2018.03.002.
   PubMed Web of Science ®Google Scholar
• Achek A, Yesudhas D, Choi S. Toll-like receptors: promising therapeutic targets for inflammatory diseases. Arch Pharm Res 2016;39(8):1032–1049. doi:10.1007/s12272-016-0806-9.
   PubMed Web of Science ®Google Scholar
• Henrick BM, Yao X-D, Taha AY, et al. Insights into soluble toll-like receptor 2 as a downregulator of virally induced inflammation. Front Immunol 2016;7:291. doi:10.3389/fimmu.2016.00291.
   PubMed Web of Science ®Google Scholar
• Zunt SL, Burton LV, Goldblatt LI, et al. Soluble forms of toll-like receptor 4 are present in human saliva and modulate tumour necrosis factor-alpha secretion by macrophage-like cells . Clin Exp Immunol 2009;156(2):285–293. doi:10.1111/j.1365-2249.2009.03854.x.
   PubMed Web of Science ®Google Scholar
• ten Oever J, Kox M, van de Veerdonk FL, et al. The discriminative capacity of soluble Toll-like receptor (sTLR)2 and sTLR4 in inflammatory diseases. BMC Immunol 2014;15:55. doi:10.1186/s12865-014-0055-y.
   PubMed Web of Science ®Google Scholar
• Sokół B, Wąsik N, Jankowski R, et al. Soluble toll-like receptors 2 and 4 in cerebrospinal fluid of patients with acute hydrocephalus following aneurysmal subarachnoid haemorrhage. PLoS One 2016;11(5):e0156171. doi:10.1371/journal.pone.0156171.
   PubMed Web of Science ®Google Scholar
• Kumar V. Inflammasomes: Pandora's box for sepsis. J Inflamm Res 2018;11:477–502. doi:10.2147/JIR.S178084.
   PubMed Web of Science ®Google Scholar
• Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol 2010;11(9):785–797. doi:10.1038/ni.1923.
   PubMed Web of Science ®Google Scholar
• Bulla R, Bossi F, Tedesco F. The complement system at the embryo implantation site: friend or foe? Front Immunol 2012;3:55.doi:10.3389/fimmu.2012.00055.
   PubMed Web of Science ®Google Scholar
• Agostinis C, Tedesco F, Bulla R. Alternative functions of the complement protein C1q at embryo implantation site. J Reprod Immunol 2017;119:74–80. doi:10.1016/j.jri.2016.09.001.
   PubMed Web of Science ®Google Scholar
• Poole AZ, Kitchen SA, Weis VM. The role of complement in cnidarian-dinoflagellate symbiosis and immune challenge in the sea anemone Aiptasia pallida. Front Microbiol 2016;7:519. doi:10.3389/fmicb.2016.00519.
   PubMed Web of Science ®Google Scholar
• Al-Sharif WZ, Sunyer JO, Lambris JD, Smith LC. Sea urchin coelomocytes specifically express a homologue of the complement component C3. J Immunol 1998;160(6):2983–2997.
   PubMed Web of Science ®Google Scholar
• Elvington M, Liszewski MK, Atkinson JP. Evolution of the complement system: from defense of the single cell to guardian of the intravascular space. Immunol Rev 2016;274(1):9–15. doi:10.1111/imr.12474.
   PubMed Web of Science ®Google Scholar
• Reid KBM. Complement component C1q: historical perspective of a functionally versatile, and structurally unusual, serum protein. Front Immunol 2018;9:764. doi:10.3389/fimmu.2018.00764.
   PubMed Web of Science ®Google Scholar
• Nonaka M, Smith SL. Complement system of bony and cartilaginous fish. Fish Shellfish Immunol 2000;10(3):215–228. doi:10.1006/fsim.1999.0252.
   PubMed Web of Science ®Google Scholar
• Jensen JA, Festa E, Smith DS, Cayer M. The complement system of the nurse shark: hemolytic and comparative characteristics. Science (New York, NY) 1981;214(4520):566–569. doi:10.1126/science.7291995.
   Google Scholar
• Nonaka M, Kimura A. Genomic view of the evolution of the complement system. Immunogenetics 2006;58(9):701–713. doi:10.1007/s00251-006-0142-1.
   PubMed Web of Science ®Google Scholar
• Gauthier MEA, Du Pasquier L, Degnan BM. The genome of the sponge Amphimedon queenslandica provides new perspectives into the origin of toll-like and interleukin 1 receptor pathways. Evol Dev 2010;12(5):519–533. doi:10.1111/j.1525-142X.2010.00436.x.
   PubMed Web of Science ®Google Scholar
• Anderson KV, Jurgens G, Nusslein-Volhard C. Establishment of dorsal-ventral polarity in the Drosophila embryo: genetic studies on the role of the Toll gene product. Cell 1985;42(3):779–789.
   PubMed Web of Science ®Google Scholar
• Hashimoto C, Hudson KL, Anderson KV. The Toll gene of drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell 1988;52(2):269–279.
   PubMed Web of Science ®Google Scholar
• Ferrandon D, Imler JL, Hetru C, Hoffmann JA. The Drosophila systemic immune response: sensing and signalling during bacterial and fungal infections. Nat Rev Immunol 2007;7(11):862–874. doi:10.1038/nri2194.
   PubMed Web of Science ®Google Scholar
• Irazoqui JE, Urbach JM, Ausubel FM. Evolution of host innate defence: insights from C. elegans and primitive invertebrates. Nat Rev Immunol 2010;10(1):47–58. doi:10.1038/nri2689.
   PubMed Web of Science ®Google Scholar
• Weber ANR, Tauszig-Delamasure S, Hoffmann JA, et al. Binding of the Drosophila cytokine Spatzle to toll is direct and establishes signaling. Nat Immunol 2003;4(8):794–800. doi:10.1038/ni955.
   PubMed Web of Science ®Google Scholar
• Arnot CJ, Gay NJ, Gangloff M. Molecular mechanism that induces activation of spätzle, the ligand for the drosophila toll receptor. J Biol Chem 2010;285(25):19502–19509. doi:10.1074/jbc.M109.098186.
   PubMed Web of Science ®Google Scholar
• Lewis M, Arnot CJ, Beeston H, et al. Cytokine Spatzle binds to the Drosophila immunoreceptor toll with a neurotrophin-like specificity and couples receptor activation . Proc Natl Acad Sci U S A 2013;110(51):20461–20466. doi:10.1073/pnas.1317002110.
   PubMed Web of Science ®Google Scholar
• Lu B, Pang PT, Woo NH. The yin and yang of neurotrophin action. Nat Rev Neurosci 2005;6(8):603–614. doi:10.1038/nrn1726.
   PubMed Web of Science ®Google Scholar
• Nakamoto M, Moy RH, Xu J, et al. Virus recognition by toll-7 activates antiviral autophagy in Drosophila. Immunity 2012;36(4):658–667. doi:10.1016/j.immuni.2012.03.003.
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011;34(5):637–650. doi:10.1016/j.immuni.2011.05.006.
   PubMed Web of Science ®Google Scholar
• Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell 2014;157(5):1013–1022. doi:10.1016/j.cell.2014.04.007.
   PubMed Web of Science ®Google Scholar
• Knodler LA, Crowley SM, Sham HP, et al. Noncanonical inflammasome activation of caspase-4/caspase-11 mediates epithelial defenses against enteric bacterial pathogens. Cell Host Microbe 2014;16:249–256. doi:10.1016/j.chom.2014.07.002.
   PubMed Web of Science ®Google Scholar
• Russo AJ, Behl B, Banerjee I, Rathinam V. Emerging insights into noncanonical inflammasome recognition of microbes. J Mol Biol 2018;430(2):207–216. doi:10.1016/j.jmb.2017.10.003.
   PubMed Web of Science ®Google Scholar
• Lamkanfi M, Declercq W, Kalai M, et al. Alice in caspase land. A phylogenetic analysis of caspases from worm to man. Cell Death Differ 2002;9(4):358–361. doi:10.1038/sj/cdd/4400989.
   PubMed Web of Science ®Google Scholar
• Boyce M, Degterev A, Yuan J. Caspases: an ancient cellular sword of Damocles. Cell Death Differ 2004;11(1):29–37. doi:10.1038/sj.cdd.4401339.
   PubMed Web of Science ®Google Scholar
• Cikala M, Wilm B, Hobmayer E, et al. Identification of caspases and apoptosis in the simple metazoan Hydra. Curr Biol 1999;9(17):959–962.
   PubMed Web of Science ®Google Scholar
• Shaham S. Identification of multiple Caenorhabditis elegans caspases and their potential roles in proteolytic cascades. J Biol Chem 1998;273(52):35109–35117. doi:10.1074/jbc.273.52.35109.
   PubMed Web of Science ®Google Scholar
• Sakamaki K, Satou Y. Caspases: evolutionary aspects of their functions in vertebrates. J Fish Biol 2009;74(4):727–753. doi:10.1111/j.1095-8649.2009.02184.x.
   PubMed Web of Science ®Google Scholar
• Wiens M, Krasko A, Perovic S, Muller WE. Caspase-mediated apoptosis in sponges: cloning and function of the phylogenetic oldest apoptotic proteases from Metazoa. Biochim Biophys Acta 2003;1593(2–3):179–189.
   PubMed Web of Science ®Google Scholar
• López-Castejón G, Sepulcre MP, Mulero I, et al. Molecular and functional characterization of gilthead seabream Sparus aurata caspase-1: the first identification of an inflammatory caspase in fish. Mol Immunol 2008;45(1):49–57. doi:10.1016/j.molimm.2007.05.015.
   PubMed Web of Science ®Google Scholar
• Maltez VI, Miao EA. Reassessing the evolutionary importance of inflammasomes. J Immunol 2016;196(3):956–962. doi:10.4049/jimmunol.1502060.
   PubMed Web of Science ®Google Scholar
• Angosto D, López-Castejón G, López-Muñoz A, et al. Evolution of inflammasome functions in vertebrates: inflammasome and caspase-1 trigger fish macrophage cell death but are dispensable for the processing of IL-1beta. Innate Immun 2012;18(6):815–824. doi:10.1177/1753425912441956.
   PubMed Web of Science ®Google Scholar
• Lin XY, Choi MS, Porter AG. Expression analysis of the human caspase-1 subfamily reveals specific regulation of the CASP5 gene by lipopolysaccharide and interferon-gamma. J Biol Chem 2000;275(51):39920–39926. doi:10.1074/jbc.M007255200.
   PubMed Web of Science ®Google Scholar
• Kumar S, Hanning CR, Brigham-Burke MR, et al. Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production. Cytokine 2002;18(2):61–71.
   PubMed Web of Science ®Google Scholar
• Kang SJ, Wang S, Hara H, et al. Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions. J Cell Biol 2000;149(3):613–622.
   PubMed Web of Science ®Google Scholar
• Brunette RL, Young JM, Whitley DG, et al. Extensive evolutionary and functional diversity among mammalian AIM2-like receptors. J Exp Med 2012;209(11):1969–1983. doi:10.1084/jem.20121960.
   PubMed Web of Science ®Google Scholar
• von Moltke J, Ayres JS, Kofoed EM, et al. Recognition of bacteria by inflammasomes. Annu Rev Immunol 2013;31:73–106. doi:10.1146/annurev-immunol-032712-095944.
   PubMed Web of Science ®Google Scholar
• Chavarría-Smith J, Mitchell PS, Ho AM, et al. Functional and evolutionary analyses identify proteolysis as a general mechanism for NLRP1 inflammasome activation. PLoS Pathog 2016;12(12):e1006052. doi:10.1371/journal.ppat.1006052.
   PubMed Web of Science ®Google Scholar
• Lukácsi S, Nagy-Baló Z, Erdei A, et al. The role of CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in complement-mediated phagocytosis and podosome formation by human phagocytes. Immunol Lett 2017;189:64–72. doi:10.1016/j.imlet.2017.05.014.
   PubMed Web of Science ®Google Scholar
• Brown EJ. Complement receptors and phagocytosis. Curr Opin Immunol 1991;3(1):76–82.
   PubMed Web of Science ®Google Scholar
• Campagne MVL, Wiesmann C, Brown EJ. Macrophage complement receptors and pathogen clearance. Cell Microbiol 2007;9:2095–2102. doi:10.1111/j.1462-5822.2007.00981.x.
   PubMed Web of Science ®Google Scholar
• Holers VM, Kinoshita T, Molina H. The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function. Immunol Today 1992;13(6):231–236.
   PubMedGoogle Scholar
• Caron E, Hall A. Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science 1998;282(5394):1717–1721.
   PubMed Web of Science ®Google Scholar
• Shi Y, Tohyama Y, Kadono T, et al. Protein-tyrosine kinase Syk is required for pathogen engulfment in complement-mediated phagocytosis. Blood 2006;107(11):4554–4562. doi:10.1182/blood-2005-09-3616.
   PubMed Web of Science ®Google Scholar
• Tohyama Y, Yamamura H. Complement-mediated phagocytosis-the role of Syk. IUBMB Life 2006;58(5–6):304–308. doi:10.1080/15216540600746377.
   PubMed Web of Science ®Google Scholar
• Hajishengallis G, Lambris JD. Crosstalk pathways between Toll-like receptors and the complement system. Trends Immunol 2010;31(4):154–163. doi:10.1016/j.it.2010.01.002.
   PubMed Web of Science ®Google Scholar
• Hajishengallis G, Lambris JD. More than complementing tolls: complement-toll-like receptor synergy and crosstalk in innate immunity and inflammation. Immunol Rev 2016;274(1):233–244. doi:10.1111/imr.12467.
   PubMed Web of Science ®Google Scholar
• Kagan JC, Medzhitov R. Phosphoinositide-mediated adaptor recruitment controls toll-like receptor signaling. Cell 2006;125(5):943–955. doi:10.1016/j.cell.2006.03.047.
   PubMed Web of Science ®Google Scholar
• Ermert D, Weckel A, Magda M, et al. Human IgG increases Virulence of Streptococcus pyogenes through complement evasion. J Immunol (Baltimore, Md: 1950) 2018;200:3495–3505. doi:10.4049/jimmunol.180009.
   PubMed Web of Science ®Google Scholar
• Hoang KV, Rajaram MVS, Curry HM, et al. Complement receptor 3-mediated inhibition of inflammasome priming by Ras GTPase-activating protein during Francisella tularensis phagocytosis by human mononuclear phagocytes. Front Immunol 2018;9:561. doi:10.3389/fimmu.2018.00561.
   PubMed Web of Science ®Google Scholar
• Suresh R, Chandrasekaran P, Sutterwala FS, Mosser DM. Complement-mediated ‘bystander’ damage initiates host NLRP3 inflammasome activation. J Cell Sci 2016;129(9):1928–1939. doi:10.1242/jcs.179291.
   PubMed Web of Science ®Google Scholar
• Helmy KY, Katschke KJ, Jr., Gorgani NN, et al. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 2006;124(5):915–927. doi:10.1016/j.cell.2005.12.039.
   PubMed Web of Science ®Google Scholar
• Lee MY, Kim WJ, Kang YJ, et al. Z39Ig is expressed on macrophages and may mediate inflammatory reactions in arthritis and atherosclerosis. J Leukoc Biol 2006;80(4):922–928. doi:10.1189/jlb.0306160.
   PubMed Web of Science ®Google Scholar
• Vogt L, Schmitz N, Kurrer MO, et al. VSIG4, a B7 family-related protein, is a negative regulator of T cell activation. J Clin Invest 2006;116(10):2817–2826. doi:10.1172/JCI25673.
   PubMed Web of Science ®Google Scholar
• He JQ, Wiesmann C, van Lookeren Campagne M. A role of macrophage complement receptor CRIg in immune clearance and inflammation. Mol Immunol 2008;45(16):4041–4047. doi:10.1016/j.molimm.2008.07.011.
   PubMed Web of Science ®Google Scholar
• Reyes L, Wolfe B, Golos T. Hofbauer cells: placental macrophages of fetal origin. Results Probl Cell Differ 2017;62:45–60. doi:10.1007/978-3-319-54090-0_3.
   PubMedGoogle Scholar
• Ghebrehiwet B, Hosszu KK, Valentino A, et al. Monocyte expressed macromolecular C1 and C1q receptors as molecular sensors of danger: implications in SLE. Front Immunol 2014;5:278. doi:10.3389/fimmu.2014.00278.
   PubMed Web of Science ®Google Scholar
• Peerschke EIB, Ghebrehiwet B. The contribution of gC1qR/p33 in infection and inflammation. Immunobiology 2007;212(4–5):333–342. doi:10.1016/j.imbio.2006.11.011.
   PubMed Web of Science ®Google Scholar
• Peerschke EI, Ghebrehiwet B. cC1qR/CR and gC1qR/p33: observations in cancer. Mol Immunol 2014;61(2):100–109. doi:10.1016/j.molimm.2014.06.011.
   PubMed Web of Science ®Google Scholar
• Ghebrehiwet B, Hosszu KH, Peerschke EI. C1q as an autocrine and paracrine regulator of cellular functions. Mol Immunol 2017;84:26–33. doi:10.1016/j.molimm.2016.11.003.
   PubMed Web of Science ®Google Scholar
• Fraser DA, Laust AK, Nelson EL, Tenner AJ. C1q differentially modulates phagocytosis and cytokine responses during ingestion of apoptotic cells by human monocytes, macrophages, and dendritic cells. J Immunol (Baltimore, Md: 1950) 2009;183(10):6175–6185. doi:10.4049/jimmunol.0902232.
   PubMed Web of Science ®Google Scholar
• Kang YH, Urban BC, Sim RB, Kishore U. Human complement Factor H modulates C1q-mediated phagocytosis of apoptotic cells. Immunobiology 2012;217(4):455–464. doi:10.1016/j.imbio.2011.10.008.
   PubMed Web of Science ®Google Scholar
• Ferreira VP, Pangburn MK, Cortés C. Complement control protein factor H: the good, the bad, and the inadequate. Mol Immunol 2010;47(13):2187–2197. doi:10.1016/j.molimm.2010.05.007.
   PubMed Web of Science ®Google Scholar
• Losse J, Zipfel PF, Jozsi M. Factor H and factor H-related protein 1 bind to human neutrophils via complement receptor 3, mediate attachment to Candida albicans, and enhance neutrophil antimicrobial activity. J Immunol (Baltimore, Md: 1950) 2010;184(2):912–921. doi:10.4049/jimmunol.0901702.
   PubMed Web of Science ®Google Scholar
• Lu JH, Teh BK, Wang L, et al. The classical and regulatory functions of C1q in immunity and autoimmunity. Cell Mol Immunol 2008;5:9–21. doi:10.1038/cmi.2008.2.
   PubMed Web of Science ®Google Scholar
• Bijl M, Reefman E, Horst G, et al. Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement. Ann Rheumat Dis 2006;65(1):57–63. doi:10.1136/ard.2005.035733.
   PubMed Web of Science ®Google Scholar
• Ling GS, Crawford G, Buang N, et al. C1q restrains autoimmunity and viral infection by regulating CD8(+) T cell metabolism. Science (New York, NY) 2018;360(6388):558–563. doi:10.1126/science.aao4555.
   Google Scholar
• Prokhorenko I, Zubova S, Kabanov D, et al. Toll-like receptor 4 in phagocytosis of Escherichia coli by endotoxin-activated human neutrophils in whole blood. Crit Care 2012;16(Suppl. 3):P80. doi:10.1186/cc11767.
   Google Scholar
• Doyle SE, O'Connell RM, Miranda GA, et al. Toll-like receptors induce a phagocytic gene program through p38. J Exp Med 2004;199(1):81–90. doi:10.1084/jem.20031237.
   PubMed Web of Science ®Google Scholar
• Ribes S, Ebert S, Regen T, et al. Toll-like receptor stimulation enhances phagocytosis and intracellular killing of nonencapsulated and encapsulated Streptococcus pneumoniae by murine microglia. Infect Immun 2010;78(2):865–871. doi:10.1128/IAI.01110-09.
   PubMed Web of Science ®Google Scholar
• Blander JM, Medzhitov R. Regulation of phagosome maturation by signals from toll-like receptors. Science 2004;304(5673):1014–1018. doi:10.1126/science.1096158.
   PubMed Web of Science ®Google Scholar
• Kong L, Ge BX. MyD88-independent activation of a novel actin-Cdc42/Rac pathway is required for Toll-like receptor-stimulated phagocytosis. Cell Res 2008;18(7):745–755. doi:10.1038/cr.2008.65.
   PubMed Web of Science ®Google Scholar
• Laroux FS, Romero X, Wetzler L, et al. Cutting edge: MyD88 controls phagocyte NADPH oxidase function and killing of gram-negative bacteria. J Immunol (Baltimore, Md: 1950) 2005;175(9):5596–5600. doi:10.4049/jimmunol.175.9.5596.
   PubMed Web of Science ®Google Scholar
• Vulcano M, Dusi S, Lissandrini D, et al. Toll receptor-mediated regulation of NADPH oxidase in human dendritic cells. J Immunol (Baltimore, Md: 1950) 2004;173(9):5749–5756. doi:10.4049/jimmunol.173.9.5749.
   PubMed Web of Science ®Google Scholar
• Sanjuan MA, Dillon CP, Tait SW, et al. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 2007;450(7173):1253–1257. doi:10.1038/nature06421.
   PubMed Web of Science ®Google Scholar
• Sanjuan MA, Milasta S, Green DR. Toll-like receptor signaling in the lysosomal pathways. Immunol Rev 2009;227(1):203–220. doi:10.1111/j.1600-065X.2008.00732.x.
   PubMed Web of Science ®Google Scholar
• Hayashi K, Taura M, Iwasaki A. The interaction between IKKalpha and LC3 promotes type I interferon production through the TLR9-containing LAPosome. Sci Signal 2018;11:pii: eaan4144. doi:10.1126/scisignal.aan4144.
   Web of Science ®Google Scholar
• Henault J, Martinez J, Riggs JM, et al. Noncanonical autophagy is required for type I interferon secretion in response to DNA-immune complexes. Immunity 2012;37(6):986–997. doi:10.1016/j.immuni.2012.09.014.
   PubMed Web of Science ®Google Scholar
• Arredouani MS. Is the scavenger receptor MARCO a new immune checkpoint? Oncoimmunology 2014;3(10):e955709doi:10.4161/21624011.2014.955709.
   PubMed Web of Science ®Google Scholar
• Tricker E, Cheng G. With a little help from my friends: modulation of phagocytosis through TLR activation. Cell Res 2008;18(7):711doi:10.1038/cr.2008.78.
   PubMed Web of Science ®Google Scholar
• van Bruggen R, Zweers D, van Diepen A, et al. Complement receptor 3 and toll-like receptor 4 act sequentially in uptake and intracellular killing of unopsonized salmonella enterica serovar typhimurium by human neutrophils. Infect Immun 2007;75(6):2655–2660. doi:10.1128/IAI.01111-06.
   PubMed Web of Science ®Google Scholar
• Harokopakis E, Hajishengallis G. Integrin activation by bacterial fimbriae through a pathway involving CD14, toll-like receptor 2, and phosphatidylinositol-3-kinase. Eur J Immunol 2005;35(4):1201–1210. doi:10.1002/eji.200425883.
   PubMed Web of Science ®Google Scholar
• Sendide K, Reiner NE, Lee JS, et al. Cross-talk between CD14 and complement receptor 3 promotes phagocytosis of mycobacteria: regulation by phosphatidylinositol 3-kinase and cytohesin-1. J Immunol (Baltimore, Md: 1950). 2005;174(7):4210–4219. doi:10.4049/jimmunol.174.7.4210.
   PubMed Web of Science ®Google Scholar
• Arbibe L, Mira JP, Teusch N, et al. Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat Immunol 2000;1(6):533–540. doi:10.1038/82797.
   PubMed Web of Science ®Google Scholar
• Hajishengallis G, Wang M, Harokopakis E, et al. Porphyromonas gingivalis fimbriae proactively modulate beta2 integrin adhesive activity and promote binding to and internalization by macrophages. Infect Immun 2006;74(10):5658–5666. doi:10.1128/IAI.00784-06.
   PubMed Web of Science ®Google Scholar
• Wang M, Shakhatreh MA, James D, et al. Fimbrial proteins of porphyromonas gingivalis mediate in vivo virulence and exploit TLR2 and complement receptor 3 to persist in macrophages. J Immunol (Baltimore, Md: 1950) 2007;179(4):2349–2358. doi:10.4049/jimmunol.179.4.2349.
   PubMed Web of Science ®Google Scholar
• Lowell CA. Rewiring phagocytic signal transduction. Immunity 2006;24(3):243–245. doi:10.1016/j.immuni.2006.03.002.
   PubMed Web of Science ®Google Scholar
• Suresh R, Sutterwala F, Mosser D. Complement mediated phagocytosis induces the activation of the NALP3 Inflammasome (INC5P.331). J Immunol 2014;192:120.11–111.
   Web of Science ®Google Scholar
• Sokolovska A, Becker CE, Eddie Ip WK, et al. Activation of caspase-1 by the NLRP3 inflammasome regulates the NADPH oxidase NOX2 to control phagosome function. Nat Immunol 2013;14(6):543–553. doi:10.1038/ni.2595.
   PubMed Web of Science ®Google Scholar
• Shimada T, Park BG, Wolf AJ, et al. Staphylococcus aureus evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL-1beta secretion. Cell Host Microbe 2010;7:38–49. doi:10.1016/j.chom.2009.12.008.
   PubMed Web of Science ®Google Scholar
• Itoh R, Murakami I, Chou B, et al. Chlamydia pneumoniae harness host NLRP3 inflammasome-mediated caspase-1 activation for optimal intracellular growth in murine macrophages. Biochem Biophys Res Commun 2014;452(3):689–694. doi:10.1016/j.bbrc.2014.08.128.
   PubMed Web of Science ®Google Scholar
• Prebeck S, Kirschning C, Dürr S, et al. Predominant role of toll-like receptor 2 versus 4 in Chlamydia pneumoniae-induced activation of dendritic cells. J Immunol 2001;167(6):3316–3323.
   PubMed Web of Science ®Google Scholar
• Fernandes-Alnemri T, Yu JW, Juliana C, et al. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat Immunol 2010;11(5):385–393. doi:10.1038/ni.1859.
   PubMed Web of Science ®Google Scholar
• Jones JW, Kayagaki N, Broz P, et al. Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis. Proc Natl Acad Sci U S A 2010;107(21):9771–9776. doi:10.1073/pnas.1003738107.
   PubMed Web of Science ®Google Scholar
• Moretti J, Blander JM. Insights into phagocytosis-coupled activation of Pattern Recognition Receptors and Inflammasomes. Curr Opin Immunol 2014; 26:0:100–10. doi:10.1016/j.coi.2013.11.003.
   PubMed Web of Science ®Google Scholar
• Miao EA, Leaf IA, Treuting PM, et al. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol 2010;11(12):1136–1142. doi:10.1038/ni.1960.
   PubMed Web of Science ®Google Scholar
• Schotte P, Denecker G, Van Den Broeke A, et al. Targeting Rac1 by the Yersinia effector protein YopE inhibits caspase-1-mediated maturation and release of interleukin-1beta. J Biol Chem 2004;279(24):25134–25142. doi:10.1074/jbc.M401245200.
   PubMed Web of Science ®Google Scholar
• Higa N, Toma C, Nohara T, et al. Lose the battle to win the war: bacterial strategies for evading host inflammasome activation. Trends Microbiol 2013;21(7):342–349. doi:10.1016/j.tim.2013.04.005.
   PubMed Web of Science ®Google Scholar
• Brodsky IE, Palm NW, Sadanand S, et al. A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system. Cell Host Microbe 2010;7:376–387. doi:10.1016/j.chom.2010.04.009.
   PubMed Web of Science ®Google Scholar
• Chen K, Shanmugam NKN, Pazos MA, et al. Commensal bacteria-induced inflammasome activation in mouse and human macrophages is dependent on potassium efflux but does not require phagocytosis or bacterial viability. PLoS One 2016;11(8):e0160937. doi:10.1371/journal.pone.0160937.
   PubMed Web of Science ®Google Scholar
• Couturier J, Stancu I-C, Schakman O, et al. Activation of phagocytic activity in astrocytes by reduced expression of the inflammasome component ASC and its implication in a mouse model of Alzheimer disease. J Neuroinflammat 2016;13:20. doi:10.1186/s12974-016-0477-y.
   PubMed Web of Science ®Google Scholar
• Lee CC, Avalos AM, Ploegh HL. Accessory molecules for Toll-like receptors and their function. Nat Rev Immunol 2012;12(3):168–179. doi:10.1038/nri3151.
   PubMed Web of Science ®Google Scholar
• Tahara K, Kim H-D, Jin J-J, et al. Role of toll-like receptor signalling in Abeta uptake and clearance. Brain 2006;129(Pt 11):3006–3019. doi:10.1093/brain/awl249.
   PubMed Web of Science ®Google Scholar
• Aderem A. Phagocytosis and the inflammatory response. J Infect Dis 2003;187(s2):S340–S345. doi:10.1086/374747.
   PubMedGoogle Scholar
• Heckmann BL, Boada-Romero E, Cunha LD, et al. LC3-associated phagocytosis and inflammation. J Mol Biol 2017;429(23):3561–3576. doi:10.1016/j.jmb.2017.08.012.
   PubMed Web of Science ®Google Scholar
• Lotze MT, Herberman RB. Cancer as a chronic inflammatory disease: role of immunotherapy. In: Morgan DW, Forssmann UJ, Nakada MT, editors. Cancer and inflammation. Basel: Birkhäuser Basel; 2004. pp 21–51.
   Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420(6917):860–867. doi:10.1038/nature01322.
   PubMed Web of Science ®Google Scholar
• Coussens LM, Zitvogel L, Palucka AK. Neutralizing tumor-promoting chronic inflammation: a magic bullet?. Science (New York, NY) 2013;339(6117):286–291. doi:10.1126/science.1232227.
   Google Scholar
• Mangsbo SM, Sanchez J, Anger K, et al. Complement activation by CpG in a human whole blood loop system: mechanisms and immunomodulatory effects. J Immunol (Baltimore, Md: 1950) 2009;183(10):6724–6732. doi:10.4049/jimmunol.0902374.
   PubMed Web of Science ®Google Scholar
• Zhang X, Kimura Y, Fang C, et al. Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood 2007;110(1):228–236. doi:10.1182/blood-2006-12-063636.
   PubMed Web of Science ®Google Scholar
• Ullah MO, Sweet MJ, Mansell A, et al. TRIF-dependent TLR signaling, its functions in host defense and inflammation, and its potential as a therapeutic target. J Leukoc Biol 2016;100(1):27–45. doi:10.1189/jlb.2RI1115-531R.
   PubMed Web of Science ®Google Scholar
• Harris CL, Pettigrew DM, Lea SM, Morgan BP. Decay-accelerating factor must bind both components of the complement alternative pathway C3 convertase to mediate efficient decay. J Immunol 2007;178(1):352–359.
   PubMed Web of Science ®Google Scholar
• Sogabe H, Nangaku M, Ishibashi Y, et al. Increased susceptibility of decay-accelerating factor deficient mice to anti-glomerular basement membrane glomerulonephritis. J Immunol 2001;167(5):2791–2797.
   PubMed Web of Science ®Google Scholar
• Kim DD, Song WC. Membrane complement regulatory proteins. Clin Immunol 2006;118(2–3):127–136. doi:10.1016/j.clim.2005.10.014.
   PubMed Web of Science ®Google Scholar
• Verschoor A, Karsten CM, Broadley SP, et al. Old dogs-new tricks: immunoregulatory properties of C3 and C5 cleavage fragments. Immunol Rev 2016;274(1):112–126. doi:10.1111/imr.12473.
   PubMed Web of Science ®Google Scholar
• Freeley S, Kemper C, Le Friec G. The “ins and outs” of complement-driven immune responses. Immunol Rev 2016;274(1):16–32. doi:10.1111/imr.12472.
   PubMed Web of Science ®Google Scholar
• Klos A, Tenner AJ, Johswich K-O, et al. The role of the anaphylatoxins in health and disease. Mol Immunol 2009;46(14):2753–2766. doi:10.1016/j.molimm.2009.04.027.
   PubMed Web of Science ®Google Scholar
• Sunderhauf A, Skibbe K, Preisker S, et al. Regulation of epithelial cell expressed C3 in the intestine – relevance for the pathophysiology of inflammatory bowel disease? Mol Immunol 2017;90:227–238. doi:10.1016/j.molimm.2017.08.003.
   PubMed Web of Science ®Google Scholar
• Pope MR, Hoffman SM, Tomlinson S, Fleming SD. Complement regulates TLR4-mediated inflammatory responses during intestinal ischemia reperfusion. Mol Immunol 2010;48(1-3):356–364. doi:10.1016/j.molimm.2010.07.004.
   PubMed Web of Science ®Google Scholar
• Goering J, Pope MR, Fleming SD. TLR2 regulates complement-mediated inflammation induced by blood loss during hemorrhage. Shock (Augusta, Ga) 2016;45(1):33–39. doi:10.1097/SHK.0000000000000477.
   PubMed Web of Science ®Google Scholar
• Lappegard KT, Christiansen D, Pharo A, et al. Human genetic deficiencies reveal the roles of complement in the inflammatory network: lessons from nature. Proc Natl Acad Sci U S A 2009;106(37):15861–15866. doi:10.1073/pnas.0903613106.
   PubMed Web of Science ®Google Scholar
• Lau C, Nygård S, Fure H, et al. CD14 and complement crosstalk and largely mediate the transcriptional response to Escherichia coli in human whole blood as revealed by DNA microarray. PLoS One 2015;10(2):e0117261. doi:10.1371/journal.pone.0117261.
   PubMed Web of Science ®Google Scholar
• Brekke OL, Christiansen D, Fure H, et al. The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood. J Leukocyte Biol 2007;81(6):1404–1413. doi:10.1189/jlb.0806538.
   PubMed Web of Science ®Google Scholar
• Zanoni I, Ostuni R, Marek LR, et al. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 2011;147(4):868–880. doi:10.1016/j.cell.2011.09.051.
   PubMed Web of Science ®Google Scholar
• Rajaiah R, Perkins DJ, Ireland DDC, Vogel SN. CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance. Proc Natl Acad Sci U S A 2015;112(27):8391–8396. doi:10.1073/pnas.1424980112.
   PubMed Web of Science ®Google Scholar
• van Bergenhenegouwen J, Plantinga TS, Joosten LA, et al. TLR2 & Co: a critical analysis of the complex interactions between TLR2 and coreceptors. J Leukocyte Biol 2013;94:885–902. doi:10.1189/jlb.0113003.
   PubMed Web of Science ®Google Scholar
• Raby AC, Holst B, Le Bouder E, et al. Targeting the TLR co-receptor CD14 with TLR2-derived peptides modulates immune responses to pathogens. Sci Translat Med 2013;5(185):185ra64. doi:10.1126/scitranslmed.3005544.
   PubMed Web of Science ®Google Scholar
• Silva Ta D, Zorzetto-Fernandes ALV, Cecílio NT, et al. CD14 is critical for TLR2-mediated M1 macrophage activation triggered by N-glycan recognition. Scientific Rep 2017;7:7083. doi:10.1038/s41598-017-07397-0.
   PubMed Web of Science ®Google Scholar
• Tan Y, Zanoni I, Cullen TW, et al. Mechanisms of toll-like receptor 4 endocytosis reveal a common immune-evasion strategy used by pathogenic and commensal bacteria. Immunity 2015;43(5):909–922. doi:10.1016/j.immuni.2015.10.008.
   PubMed Web of Science ®Google Scholar
• Wang M, Krauss JL, Domon H, et al. Microbial hijacking of complement-toll-like receptor crosstalk. Sci Signal 2010;3(109):ra11 doi:10.1126/scisignal.2000697.
   PubMed Web of Science ®Google Scholar
• Serezani CH, Ballinger MN, Aronoff DM, Peters-Golden M. Cyclic AMP: master regulator of innate immune cell function. Am J Respir Cell Mol Biol 2008;39(2):127–132. doi:10.1165/rcmb.2008-0091TR.
   PubMed Web of Science ®Google Scholar
• Koleva M, Schlaf G, Landmann R, et al. Induction of anaphylatoxin C5a receptors in rat hepatocytes by lipopolysaccharide in vivo: mediation by interleukin-6 from Kupffer cells. Gastroenterology 2002;122(3):697–708.
   PubMed Web of Science ®Google Scholar
• Hawlisch H, Belkaid Y, Baelder R, et al. C5a negatively regulates toll-like receptor 4-induced immune responses. Immunity 2005;22(4):415–426. doi:10.1016/j.immuni.2005.02.006.
   PubMed Web of Science ®Google Scholar
• Rittirsch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nat Rev Immunol 2008;8(10):776–787. doi:10.1038/nri2402.
   PubMed Web of Science ®Google Scholar
• Chen N-J, Mirtsos C, Suh D, et al. C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a. Nature 2007;446(7132):203–207. doi:10.1038/nature05559.
   PubMed Web of Science ®Google Scholar
• Gerard NP, Lu B, Liu P, et al. An anti-inflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2. J Biol Chem 2005;280(48):39677–39680. doi:10.1074/jbc.C500287200.
   PubMed Web of Science ®Google Scholar
• Kim T, Yoon J, Cho H, et al. Downregulation of lipopolysaccharide response in Drosophila by negative crosstalk between the AP1 and NF-kappaB signaling modules. Nat Immunol 2005;6(2):211–218. doi:10.1038/ni1159.
   PubMed Web of Science ®Google Scholar
• Shaulian E, Karin M. AP-1 in cell proliferation and survival. Oncogene 2001;20(19):2390–2400. doi:10.1038/sj.onc.1204383.
   PubMed Web of Science ®Google Scholar
• Foletta VC, Segal DH, Cohen DR. Transcriptional regulation in the immune system: all roads lead to AP-1. J Leukocyte Biol 1998;63(2):139–152.
   PubMed Web of Science ®Google Scholar
• Calao M, Burny A, Quivy V, et al. A pervasive role of histone acetyltransferases and deacetylases in an NF-kappaB-signaling code. Trends Biochem Sci 2008;33(7):339–349. doi:10.1016/j.tibs.2008.04.015.
   PubMed Web of Science ®Google Scholar
• Wen AY, Sakamoto KM, Miller LS. The role of the transcription factor CREB in immune function. J Immunol (Baltimore, Md: 1950) 2010;185(11):6413–6419. doi:10.4049/jimmunol.1001829.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang X, Yang H, et al. Kinase AKT controls innate immune cell development and function. Immunology 2013;140(2):143–152. doi:10.1111/imm.12123.
   PubMed Web of Science ®Google Scholar
• Waggoner SN, Cruise MW, Kassel R, Hahn YS. gC1q receptor ligation selectively down-regulates human IL-12 production through activation of the phosphoinositide 3-kinase pathway. J Immunol (Baltimore, Md: 1950). 2005;175(7):4706–4714. doi:10.4049/jimmunol.175.7.4706.
   PubMed Web of Science ®Google Scholar
• Fukao T, Koyasu S. PI3K and negative regulation of TLR signaling. Trends Immunol 2003;24(7):358–363.
   PubMed Web of Science ®Google Scholar
• Yamada M, Oritani K, Kaisho T, et al. Complement C1q regulates LPS-induced cytokine production in bone marrow-derived dendritic cells. Eur J Immunol 2004;34(1):221–230. doi:10.1002/eji.200324026.
   PubMed Web of Science ®Google Scholar
• Waggoner SN, Hall CH, Hahn YS. HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production. J Leukoc Biol 2007;82(6):1407–1419. doi:10.1189/jlb.0507268.
   PubMed Web of Science ®Google Scholar
• Cummings KL, Waggoner SN, Tacke R, Hahn YS. Role of complement in immune regulation and its exploitation by virus. Viral Immunol 2007;20(4):505–524. doi:10.1089/vim.2007.0061.
   PubMed Web of Science ®Google Scholar
• Son M, Diamond B, Santiago-Schwarz F. Fundamental role of C1q in autoimmunity and inflammation. Immunol Res 2015;63(1–3):101–106. doi:10.1007/s12026-015-8705-6.
   PubMed Web of Science ®Google Scholar
• Ghebrehiwet B, Peerschke EI. Role of C1q and C1q receptors in the pathogenesis of systemic lupus erythematosus. Curr Direct Autoimmun 2004;7:87–97.
   PubMedGoogle Scholar
• Kohl J. The role of complement in danger sensing and transmission. IR 2006;34(2):157–176. doi:10.1385/IR:34:2:157.
   Google Scholar
• Ohno M, Hirata T, Enomoto M, et al. A putative chemoattractant receptor, C5L2, is expressed in granulocyte and immature dendritic cells, but not in mature dendritic cells. Mol Immunol 2000;37(8):407–412.
   PubMed Web of Science ®Google Scholar
• Strainic MG, Liu J, Huang D, et al. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity 2008;28(3):425–435. doi:10.1016/j.immuni.2008.02.001.
   PubMed Web of Science ®Google Scholar
• Peng Q, Li K, Wang N, et al. Dendritic cell function in allostimulation is modulated by C5aR signaling. J Immunol 2009;183(10):6058–6068. doi:10.4049/jimmunol.0804186.
   PubMed Web of Science ®Google Scholar
• Kalaany NY, Sabatini DM. Tumours with PI3K activation are resistant to dietary restriction. Nature 2009;458(7239):725–731. doi:10.1038/nature07782.
   PubMed Web of Science ®Google Scholar
• Li K, Fazekasova H, Wang N, et al. Functional modulation of human monocytes derived DCs by anaphylatoxins C3a and C5a. Immunobiology 2012;217(1):65–73. doi:10.1016/j.imbio.2011.07.033.
   PubMed Web of Science ®Google Scholar
• Danial NN, Gramm CF, Scorrano L, et al. BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 2003;424(6951):952–956. doi:10.1038/nature01825.
   PubMed Web of Science ®Google Scholar
• Hess C, Kemper C. Complement-mediated regulation of metabolism and basic cellular processes. Immunity 2016;45(2):240–254. doi:10.1016/j.immuni.2016.08.003.
   PubMed Web of Science ®Google Scholar
• Vacaflores A, Chapman NM, Harty JT, et al. Exposure of human CD4 T Cells to IL-12 results in enhanced TCR-induced cytokine production, altered TCR signaling, and increased oxidative metabolism. PLoS One 2016;11(6):e0157175. doi:10.1371/journal.pone.0157175.
   PubMed Web of Science ®Google Scholar
• Henry CJ, Ornelles DA, Mitchell LM, et al. IL-12 produced by dendritic cells augments CD8+ T cell activation through the production of the chemokines CCL1 and CCL17. J Immunol (Baltimore, Md: 1950) 2008;181(12):8576–8584. doi:10.4049/jimmunol.181.12.8576.
   PubMed Web of Science ®Google Scholar
• Starbeck-Miller GR, Xue H-H, Harty JT. IL-12 and type I interferon prolong the division of activated CD8 T cells by maintaining high-affinity IL-2 signaling in vivo. J Exp Med 2014;211(1):105–120. doi:10.1084/jem.20130901.
   PubMed Web of Science ®Google Scholar
• Wierstra I. The transcription factor FOXM1 (Forkhead box M1): proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological roles. Adv Cancer Res 2013;118:97–398.
   PubMed Web of Science ®Google Scholar
• McGeachy MJ, Chen Y, Tato CM, et al. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17–producing effector T helper cells in vivo. Nat Immunol 2009;10(3):314. doi:10.1038/ni.1698.
   PubMed Web of Science ®Google Scholar
• Krausgruber T, Schiering C, Adelmann K, et al. T-bet is a key modulator of IL-23-driven pathogenic CD4+ T cell responses in the intestine. Nat Commun 2016;7:11627. doi:10.1038/ncomms11627.
   PubMed Web of Science ®Google Scholar
• Langrish CL, Chen Y, Blumenschein WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005;201(2):233–240. doi:10.1084/jem.20041257.
   PubMed Web of Science ®Google Scholar
• Zambrano-Zaragoza JF, Romo-Martínez EJ, Durán-Avelar MJ, et al. Th17 cells in autoimmune and infectious diseases. Int J Inflammat 2014;2014:1. doi:10.1155/2014/651503.
   Google Scholar
• Burkett PR, Meyer zu Horste G, Kuchroo VK. Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity. J Clin Invest 2015;125(6):2211–2219. doi:10.1172/JCI78085.
   PubMed Web of Science ®Google Scholar
• Henry CJ, Grayson JM, Brzoza-Lewis KL, et al. The roles of IL-12 and IL-23 in CD8+ T cell-mediated immunity against Listeria monocytogenes: insights from a DC vaccination model. Cell Immunol 2010;264(1):23–31. doi:10.1016/j.cellimm.2010.04.007.
   PubMed Web of Science ®Google Scholar
• Jones CL, Weiss DS. TLR2 signaling contributes to rapid inflammasome activation during F. novicida infection. PLoS One 2011;6(6):e20609. doi:10.1371/journal.pone.0020609.
   PubMed Web of Science ®Google Scholar
• He Y, Hara H, Núñez G. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci 2016;41(12):1012–1021. doi:10.1016/j.tibs.2016.09.002.
   PubMed Web of Science ®Google Scholar
• Fuentes-Antrás J, Ioan AM, Tuñón J, et al. Activation of toll-like receptors and inflammasome complexes in the diabetic cardiomyopathy-associated inflammation. Int J Endocrinol 2014;2014:1. doi:10.1155/2014/847827.
   Google Scholar
• Hanamsagar R, Hanke ML, Kielian T. Toll-like receptor (TLR) and inflammasome actions in the central nervous system: new and emerging concepts. Trends Immunol 2012;33(7):333–342. doi:10.1016/j.it.2012.03.001.
   PubMed Web of Science ®Google Scholar
• He Y, Franchi L, Nunez G. TLR agonists stimulate Nlrp3-dependent IL-1beta production independently of the purinergic P2X7 receptor in dendritic cells and in vivo. J Immunol (Baltimore, Md: 1950) 2013;190(1):334–339. doi:10.4049/jimmunol.1202737.
   PubMed Web of Science ®Google Scholar
• Fernandes-Alnemri T, Kang S, Anderson C, et al. Toll-like receptor signaling licenses IRAK1 for rapid activation of the NLRP3 inflammasome. J Immunol (Baltimore, Md: 1950) 2013;191(8):3995–3999. doi:10.4049/jimmunol.1301681.
   PubMed Web of Science ®Google Scholar
• Vayttaden SJ, Smelkinson M, Ernst OR, et al. IRAK1 attenuates TLR signaling and activates the inflammasome in response to dual-TLR stimulation. J Immunol 2017;198:75.11–75.11.
   Web of Science ®Google Scholar
• Gurung P, Li B, Subbarao Malireddi RK, et al. Chronic TLR stimulation controls NLRP3 inflammasome activation through IL-10 mediated regulation of NLRP3 expression and caspase-8 activation. Scientific Rep 2015;5:14488.
   PubMed Web of Science ®Google Scholar
• Zhao J, Kong HJ, Li H, et al. IRF-8/interferon (IFN) consensus sequence-binding protein is involved in Toll-like receptor (TLR) signaling and contributes to the cross-talk between TLR and IFN-gamma signaling pathways. J Biol Chem 2006;281(15):10073–10080. doi:10.1074/jbc.M507788200.
   PubMed Web of Science ®Google Scholar
• Karki R, Lee E, Place D, et al. IRF8 regulates transcription of naips for NLRC4 inflammasome activation. Cell 2018;173:920–933.e13.
   PubMed Web of Science ®Google Scholar
• Triantafilou K, Hughes TR, Triantafilou M, Morgan BP. The complement membrane attack complex triggers intracellular Ca2+ fluxes leading to NLRP3 inflammasome activation. J Cell Sci 2013;126(Pt 13):2903–2913. doi:10.1242/jcs.124388.
   PubMed Web of Science ®Google Scholar
• Laudisi F, Spreafico R, Evrard M, et al. Cutting edge: the NLRP3 inflammasome links complement-mediated inflammation and IL-1β release. J Immunol 2013;191(3):1006–1010. doi:10.4049/jimmunol.1300489.
   PubMed Web of Science ®Google Scholar
• Asgari E, Le Friec G, Yamamoto H, et al. C3a modulates IL-1beta secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation. Blood 2013;122(20):3473–3481. doi:10.1182/blood-2013-05-502229.
   PubMed Web of Science ®Google Scholar
• Samstad EO, Niyonzima N, Nymo S, et al. Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release. J Immunol 2014;192(6):2837–2845. doi:10.4049/jimmunol.1302484.
   PubMed Web of Science ®Google Scholar
• Duewell P, Kono H, Rayner KJ, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010;464(7293):1357–1361. doi:10.1038/nature08938.
   PubMed Web of Science ®Google Scholar
• An LL, Mehta P, Xu L, et al. Complement C5a potentiates uric acid crystal-induced IL-1β production. Eur J Immunol 2014;44(12):3669–3679. doi:10.1002/eji.201444560.
   PubMed Web of Science ®Google Scholar
• Arbore G, West EE, Spolski R, et al. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4(+) T cells. Science (New York, NY) 2016;352(6292):aad1210. doi:10.1126/science.aad1210.
   Google Scholar
• Benoit ME, Clarke EV, Morgado P, et al. Complement protein C1q directs macrophage polarization and limits inflammasome activity during the uptake of apoptotic cells. J Immunol (Baltimore, Md: 1950) 2012;188(11):5682–5693. doi:10.4049/jimmunol.1103760.
   PubMed Web of Science ®Google Scholar
• Manughian-Peter A, Ho MM, Fraser DA. Complement protein C1q suppresses macrophage inflammasome activation during clearance of modified LDL. J Immunol 2017;198:64.5–65.
   Web of Science ®Google Scholar
• Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature 2011;469(7330):323–335. doi:10.1038/nature09782.
   PubMed Web of Science ®Google Scholar
• Deretic V, Saitoh T, Akira S. Autophagy in infection, inflammation and immunity. Nat Rev Immunol 2013;13(10):722–737. doi:10.1038/nri3532.
   PubMed Web of Science ®Google Scholar
• Kuballa P, Nolte WM, Castoreno AB, Xavier RJ. Autophagy and the immune system. Annu Rev Immunol 2012;30:611–646. doi:10.1146/annurev-immunol-020711-074948.
   PubMed Web of Science ®Google Scholar
• Bhattacharya A, Eissa NT. Autophagy as a stress response pathway in the immune system. Int Rev Immunol 2015;34(5):382–402. doi:10.3109/08830185.2014.999156.
   PubMed Web of Science ®Google Scholar
• Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 2008;451(7182):1069–1075. doi:10.1038/nature06639.
   PubMed Web of Science ®Google Scholar
• Shibutani ST, Saitoh T, Nowag H, et al. Autophagy and autophagy-related proteins in the immune system. Nat Immunol 2015;16(10):1014–1024. doi:10.1038/ni.3273.
   PubMed Web of Science ®Google Scholar
• Sanjuan MA, Green DR. Eating for good health: linking autophagy and phagocytosis in host defense. Autophagy 2008;4(5):607–611.
   PubMed Web of Science ®Google Scholar
• Ogawa M, Sasakawa C. Bacterial evasion of the autophagic defense system. Curr Opin Microbiol 2006;9(1):62–68. doi:10.1016/j.mib.2005.12.007.
   PubMed Web of Science ®Google Scholar
• Ogawa M, Mimuro H, Yoshikawa Y, et al. Manipulation of autophagy by bacteria for their own benefit. Microbiol Immunol 2011;55(7):459–471. doi:10.1111/j.1348-0421.2011.00343.x.
   PubMed Web of Science ®Google Scholar
• Ma J, Underhill DM. Beta-glucan signaling connects phagocytosis to autophagy. Glycobiology 2013;23(9):1047–1051. doi:10.1093/glycob/cwt046.
   PubMed Web of Science ®Google Scholar
• Ma J, Becker C, Lowell CA, Underhill DM. Dectin-1-triggered recruitment of light chain 3 protein to phagosomes facilitates major histocompatibility complex class II presentation of fungal-derived antigens. J Biol Chem 2012;287(41):34149–34156. doi:10.1074/jbc.M112.382812.
   PubMed Web of Science ®Google Scholar
• Romao S, Munz C. LC3-associated phagocytosis. Autophagy 2014;10(3):526–528. doi:10.4161/auto.27606.
   PubMed Web of Science ®Google Scholar
• Tam JM, Mansour MK, Khan NS, et al. Dectin-1-dependent LC3 recruitment to phagosomes enhances fungicidal activity in macrophages. J Infect Dis 2014;210(11):1844–1854. doi:10.1093/infdis/jiu290.
   PubMed Web of Science ®Google Scholar
• Li YY, Ishihara S, Aziz MM, et al. Autophagy is required for toll-like receptor-mediated interleukin-8 production in intestinal epithelial cells. Int J Mol Med 2011;27:337–344.
   PubMed Web of Science ®Google Scholar
• Delgado MA, Elmaoued RA, Davis AS, et al. Toll-like receptors control autophagy. Embo J 2008;27(7):1110–1121. doi:10.1038/emboj.2008.31.
   PubMed Web of Science ®Google Scholar
• Pacquelet S, Johnson JL, Ellis BA, et al. Cross-talk between IRAK-4 and the NADPH oxidase. Biochem J 2007;403(3):451–461. doi:10.1042/BJ20061184.
   PubMedGoogle Scholar
• Underhill DM. Toll-like receptors: networking for success. Eur J Immunol 2003;33(7):1767–1775. doi:10.1002/eji.200324037.
   PubMed Web of Science ®Google Scholar
• Delgado MA, Deretic V. Toll-like receptors in control of immunological autophagy. Cell Death Differ 2009;16(7):976–983. doi:10.1038/cdd.2009.40.
   PubMed Web of Science ®Google Scholar
• Shi C-S, Kehrl JH. MyD88 and Trif target Beclin 1 to trigger autophagy in macrophages. J Biol Chem 2008;283(48):33175–33182. doi:10.1074/jbc.M804478200.
   PubMed Web of Science ®Google Scholar
• Nabar NR, Shi C-S, Kehrl JH. Chapter 6 – signaling by the toll-like receptors induces autophagy through modification of beclin 1: molecular mechanism. In: Hayat MA, editor. Immunology. Academic Press; 2018. pp 75–84.
   Google Scholar
• Franco LH, Fleuri AKA, Pellison NC, et al. Autophagy downstream of endosomal toll-like receptors signaling in macrophages is a key mechanism for resistance to leishmania major infection. J Biol Chem 2017;292:13087–13096.
   PubMed Web of Science ®Google Scholar
• Oh JE, Lee HK. Pattern recognition receptors and autophagy. Front Immunol 2014;5:300. doi:10.3389/fimmu.2014.00300.
   PubMed Web of Science ®Google Scholar
• Gyorgyi M, Miklos C, Istvan F, et al. Interaction of autophagy and toll-like receptors: a regulatory cross-talk – even in cancer cells? Curr Drug Targets 2014;15:743–752.
   PubMed Web of Science ®Google Scholar
• Moreno-Gonzalo O, Ramírez-Huesca M, Blas-Rus N, et al. HDAC6 controls innate immune and autophagy responses to TLR-mediated signalling by the intracellular bacteria Listeria monocytogenes. PLoS Pathog 2017;13(12):e1006799. doi:10.1371/journal.ppat.1006799.
   PubMed Web of Science ®Google Scholar
• Kang S-J, Tak J-H, Cho J-H, et al. Stimulation of the endosomal TLR pathway enhances autophagy-induced cell death in radiotherapy of breast cancer. Genes Genom 2010;32:599–606. doi:10.1007/s13258-010-0139-x.
   Web of Science ®Google Scholar
• Saitoh T, Fujita N, Jang MH, et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 2008;456(7219):264–268. doi:10.1038/nature07383.
   PubMed Web of Science ®Google Scholar
• Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011;469(7329):221–225. doi:10.1038/nature09663.
   PubMed Web of Science ®Google Scholar
• Nakahira K, Haspel JA, Rathinam VA, et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 2011;12(3):222–230. doi:10.1038/ni.1980.
   PubMed Web of Science ®Google Scholar
• Shimada K, Crother TR, Karlin J, et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 2012;36(3):401–414. doi:10.1016/j.immuni.2012.01.009.
   PubMed Web of Science ®Google Scholar
• Cruz CM, Rinna A, Forman HJ, et al. ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J Biol Chem 2007;282(5):2871–2879. doi:10.1074/jbc.M608083200.
   PubMed Web of Science ®Google Scholar
• Simard JC, Cesaro A, Chapeton-Montes J, et al. S100A8 and S100A9 induce cytokine expression and regulate the NLRP3 inflammasome via ROS-dependent activation of NF-kappaB(1.). PLoS One 2013;8(8):e72138. doi:10.1371/journal.pone.0072138.
   PubMed Web of Science ®Google Scholar
• Harijith A, Ebenezer DL, Natarajan V. Reactive oxygen species at the crossroads of inflammasome and inflammation. Front Physiol 2014;5:352doi:10.3389/fphys.2014.00352.
   PubMed Web of Science ®Google Scholar
• Sun Q, Fan J, Billiar TR, Scott MJ. Inflammasome and autophagy regulation – a two-way street. Mol Med 2017;23(1):188–195. doi:10.2119/molmed.2017.00077.
   PubMedGoogle Scholar
• Zhou R, Tardivel A, Thorens B, et al. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 2010;11(2):136–140. doi:10.1038/ni.1831.
   PubMed Web of Science ®Google Scholar
• Harris J, Lang T, Thomas JPW, et al. Autophagy and inflammasomes. Mol Immunol 2017;86:10–15. doi:10.1016/j.molimm.2017.02.013.
   PubMed Web of Science ®Google Scholar
• Jounai N, Kobiyama K, Shiina M, et al. NLRP4 negatively regulates autophagic processes through an association with beclin1. J Immunol (Baltimore, Md: 1950) 2011;186(3):1646–1655. doi:10.4049/jimmunol.1001654.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sauler M, Shinn AS, et al. Endothelial PINK1 mediates the protective effects of NLRP3 deficiency during lethal oxidant injury. J Immunol (Baltimore, Md: 1950) 2014;192(11):5296–5304. doi:10.4049/jimmunol.1400653.
   PubMed Web of Science ®Google Scholar
• Shi C-S, Shenderov K, Huang N-N, et al. Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol 2012;13(3):255. doi:10.1038/ni.2215.
   PubMed Web of Science ®Google Scholar
• Vorhauer J, Alaoui-El-Azher M, Wells A, Ismail N. Autophagy and inflammasome activation triggered by LPS-negative Ehrlichia is dependent on both mTOR activation and MyD88 signaling. J Immunol 2016;196:62.12–62.12.
   Web of Science ®Google Scholar
• Lin L, Rodrigues F, Kary C, et al. Complement-related regulates autophagy in neighboring cells. Cell 2017;170(1):158–171.e8. doi:10.1016/j.cell.2017.06.018.
   PubMed Web of Science ®Google Scholar
• McPhee CK, Logan MA, Freeman MR, Baehrecke EH. Activation of autophagy during cell death requires the engulfment receptor Draper. Nature 2010;465(7301):1093–1096. doi:10.1038/nature09127.
   PubMed Web of Science ®Google Scholar
• MacDonald JM, Beach MG, Porpiglia E, et al. The Drosophila cell corpse engulfment receptor Draper mediates glial clearance of severed axons. Neuron 2006;50(6):869–881. doi:10.1016/j.neuron.2006.04.028.
   PubMed Web of Science ®Google Scholar
• Rogińska D, Kawa MP, Pius-Sadowska E, et al. Depletion of the third complement component ameliorates age-dependent oxidative stress and positively modulates autophagic activity in aged retinas in a mouse model. Oxidat Med Cell Longevity 2017;2017:1.
   Google Scholar
• King BC, Kulak K, Krus U, et al. Complement component C3 is highly expressed in human pancreatic islets and prevents β cell death via ATG16L1 interaction and autophagy regulation. Cell Metabol 2019;29:202–210.e6. doi:10.1016/j.cmet.2018.09.009.
   PubMed Web of Science ®Google Scholar
• Sorbara MT, Foerster EG, Tsalikis J, et al. Complement C3 drives autophagy-dependent restriction of cyto-invasive bacteria. Cell Host Microbe 2018;23:644–652.e5. doi:10.1016/j.chom.2018.04.008.
   PubMed Web of Science ®Google Scholar
• Sancho-Shimizu V, Mostowy S. Bacterial autophagy: how to take a complement. Cell Host Microbe 2018;23(5):580–582. doi:10.1016/j.chom.2018.04.010.
   PubMed Web of Science ®Google Scholar
• Scanlon ST. Bacteria restricted via C3-mediated autophagy. Science (New York, NY) 2018;360:977–978. doi:10.1126/science.360.6392.977-d.
   Google Scholar
• Tsai Y-G, Wen Y-S, Wang J-Y, et al. Complement regulatory protein CD46 induces autophagy against oxidative stress-mediated apoptosis in normal and asthmatic airway epithelium. Scientific Rep 2018;8:12973. doi:10.1038/s41598-018-31317-5..
   PubMed Web of Science ®Google Scholar